Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yesi Shi

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Advanced Healthcare Materials|March 13, 2018
NanoTRAIL-Oncology: A Strategic Approach in Cancer Research and TherapyYesi Shi, Xin Pang, Junqing Wang, et al.
Frontiers in Oncology|January 27, 2022
Bioinspired Membrane-Coated Nanoplatform for Targeted Tumor ImmunotherapyDan Mu, Pan He, Yesi Shi, et al.
Acta Pharmaceutica Sinica. B|May 9, 2022
Bioinspired membrane-based nanomodulators for immunotherapy of autoimmune and infectious diseasesYesi Shi, Hongyan Qian, Peishi Rao, et al.
Trends in Biotechnology|May 31, 2024
Ocular RNA nanomedicine: engineered delivery nanoplatforms in treating eye diseasesYiming Zhang, Yesi Shi, Muhammad M Khan, et al.
Chemical Reviews|January 29, 2024
Chemically Modified Platforms for Better RNA TherapeuticsYesi Shi, Xueyan Zhen, Yiming Zhang, et al.
ACS Nano|December 20, 2021
Nanotransferrin-Based Programmable Catalysis Mediates Three-Pronged Induction of Oxidative Stress to Enhance Cancer ImmunotherapyShuang Bai, Zhixiang Lu, Yonghe Jiang, et al.
Small (Weinheim an Der Bergstrasse, Germany)|September 23, 2022
Amplifying Dendritic Cell Activation by Bioinspired Nanometal Organic Frameworks for Synergistic SonoimmunotherapyZhixiang Lu, Shuang Bai, Yonghe Jiang, et al.
Journal of Nanobiotechnology|February 3, 2022
Functional nanovesicles displaying anti-PD-L1 antibodies for programmed photoimmunotherapyHu Chen, Pengfei Zhang, Yesi Shi, et al.
Journal of Nanobiotechnology|December 25, 2021
Biomimetic nanoparticles blocking autophagy for enhanced chemotherapy and metastasis inhibition via reversing focal adhesion disassemblyYesi Shi, Gan Lin, Huili Zheng, et al.
Nature Reviews. Methods Primers|August 1, 2025
Nanotechnology-based mRNA vaccinesShuying Chen, Xiangang Huang, Yonger Xue, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Advanced Healthcare Materials|March 13, 2018
NanoTRAIL-Oncology: A Strategic Approach in Cancer Research and TherapyYesi Shi, Xin Pang, Junqing Wang, et al.
Frontiers in Oncology|January 27, 2022
Bioinspired Membrane-Coated Nanoplatform for Targeted Tumor ImmunotherapyDan Mu, Pan He, Yesi Shi, et al.
Acta Pharmaceutica Sinica. B|May 9, 2022
Bioinspired membrane-based nanomodulators for immunotherapy of autoimmune and infectious diseasesYesi Shi, Hongyan Qian, Peishi Rao, et al.
Trends in Biotechnology|May 31, 2024
Ocular RNA nanomedicine: engineered delivery nanoplatforms in treating eye diseasesYiming Zhang, Yesi Shi, Muhammad M Khan, et al.
Chemical Reviews|January 29, 2024
Chemically Modified Platforms for Better RNA TherapeuticsYesi Shi, Xueyan Zhen, Yiming Zhang, et al.
ACS Nano|December 20, 2021
Nanotransferrin-Based Programmable Catalysis Mediates Three-Pronged Induction of Oxidative Stress to Enhance Cancer ImmunotherapyShuang Bai, Zhixiang Lu, Yonghe Jiang, et al.
Small (Weinheim an Der Bergstrasse, Germany)|September 23, 2022
Amplifying Dendritic Cell Activation by Bioinspired Nanometal Organic Frameworks for Synergistic SonoimmunotherapyZhixiang Lu, Shuang Bai, Yonghe Jiang, et al.
Journal of Nanobiotechnology|February 3, 2022
Functional nanovesicles displaying anti-PD-L1 antibodies for programmed photoimmunotherapyHu Chen, Pengfei Zhang, Yesi Shi, et al.
Journal of Nanobiotechnology|December 25, 2021
Biomimetic nanoparticles blocking autophagy for enhanced chemotherapy and metastasis inhibition via reversing focal adhesion disassemblyYesi Shi, Gan Lin, Huili Zheng, et al.
Nature Reviews. Methods Primers|August 1, 2025
Nanotechnology-based mRNA vaccinesShuying Chen, Xiangang Huang, Yonger Xue, et al.
Pageof 2